Patent Settlement Notification Supported By FTC Workshop Participants
This article was originally published in The Tan Sheet
Executive Summary
Legislation to require notification of patent litigation settlements would be useful, provided practical challenges can be worked out, former FTC Bureau of Competition Assistant Director Richard Feinstein told a recent commission hearing on patent/antitrust issues
You may also be interested in...
Generic Delay Tactics Evolving In Wake Of Consent Decrees – Initial FTC Data
Potentially anticompetitive strategies on generics have evolved since the Federal Trade Commission began imposing consent agreements on companies that made questionable settlements, FTC states
Late-Listed Patents Need "Careful Scrutiny" By FDA, Hatch And Waxman Say
FDA should closely examine patents submitted for listing in the "Orange Book" in advance of generic competition, Sens. Edward Kennedy (D-Mass.) and Orrin Hatch (R-Utah) and Rep. Henry Waxman (D-Calif.) state in a letter to HHS Secretary Tommy Thompson.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC